A study was carried out to assess how best to help patients with chronic kidney disease (CKD) make informed decisions about which type of dialysis they prefer.

Decision-making tools (DMTs) are considered to be the gold-standard in enabling such informed choice, but are still not widely used. In this study, 2,012 patients across 48 of our clinics were empowered with the DMTs process, 71% being medically suitable for both techniques. In order to help them decide whether to start on PD, a variety of resources were offered such as patient values evaluation, written information, a DVD and visits to clinics where both haemodialysis and peritoneal dialysis (PD) were carried out.

A shared decision was taken, aligned with relatives, in 82% of cases. Most patients (92%) felt the process useful in their journey towards making a choice. Of patients suitable for both modalities, 35% chose PD, whilst chronic ascription to a PD program occurred in 31%.

Download a poster here or below of the study in short.


Care excellence

Diaverum Portugal expands its service offering

Care excellence

Diaverum launches global training programme for its clinical leaders

Chronic Kidney Disease (CKD)

2023 World Kidney Day